https://www.fiercepharma.com/pharma/sanofi-beat-out-three-suitors-its-pricey-2-5b-buyout-biotech-synthorx
https://www.fiercebiotech.com/biotech/amgen-pays-a-premium-for-five-prime-therapeutics-a-1-9b-cash-deal
https://www.fiercebiotech.com/biotech/accent-astrazeneca-take-aim-at-rna-modifiers-55m-cancer-pact
https://www.businesswire.com/news/home/20200928005493/en/Fierce-Biotech-Names-Accent-Therapeutics-as-One-of-Its-%E2%80%9CFierce-15%E2%80%9D-Biotech-Companies-of-2020
https://www.fiercebiotech.com/biotech/gilead-strikes-4-9b-forty-seven-acquisition-paying-a-hefty-premium-for-cancer-drug
Accent Therapeutics is playing in the same space as we are in terms of RNA modification.
You can see once results are out, SP jumps drastically.
- Forums
- ASX - By Stock
- Oncology - Pharma Deals News
https://www.fiercepharma.com/pharma/sanofi-beat-out-three-suitors...
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.69 |
Change
0.010(0.60%) |
Mkt cap ! $287.1M |
Open | High | Low | Value | Volume |
$1.69 | $1.70 | $1.65 | $89.01K | 53.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2342 | $1.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.70 | 5 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2342 | 1.685 |
1 | 3664 | 1.680 |
1 | 5077 | 1.660 |
1 | 1265 | 1.650 |
1 | 612 | 1.635 |
Price($) | Vol. | No. |
---|---|---|
1.695 | 5 | 1 |
1.700 | 11000 | 1 |
1.730 | 2399 | 1 |
1.750 | 952 | 2 |
1.775 | 1328 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online